Digital Content Designer
Nancy supports the Citeline editorial team with design and multimedia projects, including infographics, data visualizations, and UI/UX.
She holds a BA in Journalism and previously worked at US News & World Report as a digital producer. In her spare time, Nancy enjoys traveling, being outdoors, and attending concerts.
Latest From Nancy Pham
Big Pharma At US FDA: A Regulatory Scorecard
The breakthrough designations, approvals, and rejections for applications from the 15 biggest companies in a Pink Sheet infographic.
Accelerated Approval: Gene Therapy Confirmatory Trial Timelines Can Stretch
Pink Sheet infographic looks at the nascent space of gene therapy accelerated approvals, where confirmatory trial timelines can run many years beyond approval due to disease rarity and a focus on durability of response.
The Ongoing Efforts To Confirm DMD Treatment Benefits
Infographic outlines the current status and history of several ongoing confirmatory trials for Duchenne muscular dystrophy treatments and a proposed gene therapy. Some have seen enrollment targets and eligibility requirements change over the years, along with the estimated completion dates.
Pink Sheet’s Top Seven Infographics Of 2022
From US drug pricing to Japan’s Sakigake expedited pathway, important regulatory developments and trends are easier to understand and track with Pink Sheet graphics.
Alzheimer’s Disease Trial Designs Struggle To Turn Noise Into Sound
Infographic compares pivotal trials for Alzheimer's disease-modifying candidates from Biogen/Eisai, Lilly and Roche.
Game Time: FDA Releases Review Timeline Goals Set By MDUFA V
This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.